Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: preparation and evaluation

References

• Bolhassani A. (2011). Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer. Biochim Biophys Acta 1816:232–46.
   PubMed Web of Science ®Google Scholar
• Brooks NA, Pouniotis DS, Tang CK, et al. (2010). Cell-penetrating peptides: application in vaccine delivery. Biochim Biophys Acta 1805:25–34.
   PubMed Web of Science ®Google Scholar
• Chan KT, Li K, Liu SL, et al. (2010a). Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562. Cancer Lett 289:46–52.
   PubMed Web of Science ®Google Scholar
• Chan KT, Meng FY, Li Q, et al. (2010b). Cucurbitacin B induces apoptosis and S phace cell cycle arreat in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 294:118–24.
   PubMed Web of Science ®Google Scholar
• Chen XP, Bao JL, GUO JJ, et al. (2012). Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Colloq Inse 23:777–87.
   Google Scholar
• Dubray O, Jannin V, Demarne F, et al. (2016). In vitro investigation regarding the effects of Gelucire 44/14 and labrasol ALF on the secretory intestinal transport of P-gp substrates. Int J Pharm 515:293–9.
   PubMed Web of Science ®Google Scholar
• Erdman K, Cheung WY, Schroder H. (2008). The possible roles of food derived bioactive peptides in reducing the risk of cardiovascular diseases. J Nutr Biochem 19:643–54.
   PubMed Web of Science ®Google Scholar
• Gao ZB, Zhang LN, Sun YJ. (2012). Nanotechnology applied to overcome tumor drug resistance. J Control Release 162:45–55.
   PubMed Web of Science ®Google Scholar
• Guo F, Zhang MY, Gao Y, et al. (2017). Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation. Drug Deliv 23:2003–14.
   Web of Science ®Google Scholar
• Hou J, Sun E, Sun CY, et al. (2016). Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via novel soluplus – solutol HS15 binary mixed micelles system. Int J Pharm 512:186–93.
   PubMed Web of Science ®Google Scholar
• Jiang TY, Zhang ZH, Zhang YL, et al. (2012). Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58.
   PubMed Web of Science ®Google Scholar
• Joshi G, Kumar A, Sawant K. (2016). Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles. Drug Deliv 23:3492–504.
   PubMed Web of Science ®Google Scholar
• Kaplan IM, Wadia JS, Dowdy SF. (2005). Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102:247–53.
   PubMed Web of Science ®Google Scholar
• Kausar H, Munagaia R, Bansai SS, et al. (2013). Cucurbitacin B potently suppresses non-small-cell lung cancer growth: identification of intracellular thiols as critical targets. Cancer Lett 332:35–45.
   PubMed Web of Science ®Google Scholar
• Kenjiro K, Yoichi K, Yukako I, et al. (2006). Enhancing mechanism of Labrasol on intestinal membrane permeability of the hydrophilic drug gentamicin sulfate. Eur J Pharm Biopharm 64:82–91.
   PubMed Web of Science ®Google Scholar
• Khafagy ES, Morishita M. (2012). Oral biodrug delivery using cell-penetrating peptide. Adv Drug Deliv Rev 64:531–9.
   PubMed Web of Science ®Google Scholar
• Liu XL, Liu C, Zhang WJ, et al. (2013). Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin. Int J Pharm 448:159–67.
   PubMed Web of Science ®Google Scholar
• Mager I, Eiríksdottir E, Langel K, et al. (2010). Assessing the uptake kinetics and internalization mechanisms of cell-penetrating peptides using a quenched fluorescence assay. Biochim Biophys Acta 1798:338–43.
   PubMed Web of Science ®Google Scholar
• Milletti F. (2012). Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–60.
   PubMed Web of Science ®Google Scholar
• Molavi O, Ma ZS, Mahmud A, et al. (2008). Polymeric micelles for the solubilization and delivery of STAT3 inhibitors cucurbitacins in solid tumors. J Inter Pharm 347:118–27.
   PubMed Web of Science ®Google Scholar
• Mora NL, Bahreman A, Valikenier H, et al. (2016). Targeted anion transporter delivery by coiled-coil driven membrane fusion. Chem Sci 7:1768–72.
   PubMed Web of Science ®Google Scholar
• Ramsey JD, Flynn NH. (2015). Cell-penetrating peptides transport therapeutics into cells. Pharmacol Therapeut 154:78–86.
   PubMed Web of Science ®Google Scholar
• Rios JL, Andujar I, Escandell JM, et al. (2012). Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds. Curr Pharm Design 18:1663–76.
   PubMed Web of Science ®Google Scholar
• Senevirathne M, Kim SK. (2012). Development of bioactive peptides from fish proteins and their health promoting ability. Adv Food Nutr Res 65:235–48.
   PubMedGoogle Scholar
• Sliva LT, Carvalho A, Lang KL, et al. (2015). In vitro and in vivo antitumor activity of a novel semisynthetic derivative of Cucurbitacin B. Plos One 10:1–19.
   Web of Science ®Google Scholar
• Tannin-spitz T, Grossman S, Dovrat S, et al. (2007). Growth inhibitory activity of cucurbitacin glucosides isolated from Ctrullus colocynthis on human breast cancer cells. Biochem Pharmacol 73:56–67.
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Battaglini M, Ciofani G. (2017). Advance in the design of solid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release 264:306–32.
   PubMed Web of Science ®Google Scholar
• Thoennissen NH, Lanski GB, Doan NB, et al. (2009). Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of Gemcitabine on pancreatic cancer cells. Cancer Res 69:5678–84.
   Web of Science ®Google Scholar
• Torchilin VP. (2008). Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliver Rev 60:548–58.
   PubMed Web of Science ®Google Scholar
• Vercruysse L, Van Camp J, Smagghie G. (2005). ACE inhibitory peptides derived from enzymatic hydrolysates of animal muscle protein: a review. J Agric Food Chem 53:8106–15.
   PubMed Web of Science ®Google Scholar
• Wang FH, Wang Y, Zhang X, et al. (2014). Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery. J Control Release 174:126–36.
   PubMed Web of Science ®Google Scholar
• Xie Y, Ma YM WCH, et al. (2011). Overview and consideration on improving oral bioavailability of traditional Chinese medicine preparation. J Int Pharm Res 38:195–200.
   Google Scholar
• Yang L, Chen L, Zeng R, et al. (2010). Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate. Bioorg Med Chem 18:117–23.
   PubMed Web of Science ®Google Scholar
• Zhang JF, Hou SX, Liu HL, et al. (2005). Study on preparation and drug loading of Cucubitacin-polylactic acid nonoparticles. Chin J Chin Mater Med 6:436–9.
   Google Scholar
• Zhang X, Lin CC, Lu AP, et al. (2017). Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma. Drug Deliv 24:986–98.
   PubMed Web of Science ®Google Scholar
• Zheng J, Wang MM, Wei WQ, et al. (2016). Dietary plant lectins appear to be transported from the gut to gain access to and alter dopaminergic neurons of Caenorhabditis elegans, a potential etiology of Parkinson’s disease. Front Nutr 3:1–16.
   PubMed Web of Science ®Google Scholar
• Zhu SQ, Chen SX, Gao Y, et al. (2016). Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (sec). Drug Deliv 23:1980–91.
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Cui CC, Fang W, Lv HX. (2017). Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system. Drug Dev Ind Pharm 43:1276–82.
   PubMed Web of Science ®Google Scholar